Arrowhead Research reported -0.2 in EPS Earnings Per Share for its fourth fiscal quarter of 2020.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Eps Change
Agios Pharmaceuticals AGIO:US -1.41 0.02
Alnylam Pharmaceuticals ALNY:US $ -2.09 0.09
Anika Therapeutics ANIK:US 0.12 0.57
Arena Pharmaceuticals ARNA:US -2.1 0.41
Arrowhead Research ARWR:US -0.2 0.28
Bluebird Bio BLUE:US $ -3.01 0.07
Cerulean Pharma CERU:US $ -0.24 0.03
Dicerna Pharmaceuticals DRNA:US -0.49 0.2
Heron Therapeutics HRTX:US -0.68 0.04
Intercept Pharmaceuticals ICPT:US $ -1.58 0.03
IONIS PHARMACEUT IONS:US $ 0.44 0.66
Ligand Pharmaceuticals LGND:US $ 1.62 0.58
Merk MRK:US $ 1.32 0.42
Mirati Therapeutics MRTX:US -2.08 0.12
Moderna Inc MRNA:US -0.69 0.1
Nektar Therapeutics NKTR:US $ -0.65 0.04
Novartis NOVN:VX SF 1.34 0.18
Opko Health OPK:US $ 0.05 0.01
Sarepta Therapeutics SRPT:US -2.4 0.47
Spectrum Pharmaceuticals SPPI:US -0.37 0.09
Tg Therapeutics TGTX:US -0.71 0.1
Ultragenyx Pharmaceutical RARE:US $ 0.85 1.98
Vertex Pharmaceuticals VRTX:US $ 2.51 0.13
Xencor XNCR:US $ -0.24 0.02
YTE INCY:US $ 0.93 0.7